肺动脉导管置入对心脏手术短期结局的影响
该观察性研究纳入2010至2018年11820例开放心脏手术患者,其中4605例(39.0%)置入肺动脉导管,经1:1倾向性匹配后比较3519对患者。结果显示肺动脉导管置入未改善整体及近期心衰、二尖瓣病、三尖瓣关闭不全亚组的operative mortality,但ICU停留时间更长且红细胞输注更多,其他术后结局相似。
要点
- 肺动脉导管置入未改善心脏手术患者的手术死亡率。
- 肺动脉导管组ICU停留时间更长且红细胞输注更多。
- 卒中、脓毒症、新发肾衰竭等结局两组相似。
核心结论
- 肺动脉导管置入在心脏手术中可能获益有限,未改善手术死亡率且增加ICU停留和输血。
研究设计与样本
- 观察性研究,纳入2010至2018年11820例开放心脏手术患者,其中4605例(39.0%)置入肺动脉导管,经1:1最近邻倾向性匹配得3519对。
主要发现
- 整体队列及近期心衰、二尖瓣病、三尖瓣关闭不全亚组中,肺动脉导管与中心静脉压监测相比未改善手术死亡率。
- 肺动脉导管组ICU停留时间更长(P < .001),红细胞输注更多(P < .001)。
- 卒中、脓毒症、新发肾衰竭等术后结局两组相似(P > .05)。
关键数值与推荐
- 匹配后3519对患者均衡,肺动脉导管组ICU停留时间更长(P < .001),红细胞输注更多(P < .001)。
- 整体队列及近期心衰、二尖瓣病、三尖瓣关闭不全亚组手术死亡率无改善。
临床怎么用
- 在心脏手术围术期,不应常规依赖肺动脉导管置入以期改善短期结局。
局限性
- 本研究为观察性研究,可能存在残余混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Pulmonary artery catheterization provides continuous monitoring of hemodynamic parameters that may aid in the perioperative management of patients undergoing cardiac surgery. However, prior data suggest that pulmonary artery catheterization has limited benefit in intensive care and surgical settings. Thus, this study sought to determine the impact of pulmonary artery catheter insertion on short-term postoperative outcomes in a large, contemporaneous cohort of patients undergoing open cardiac surgery compared with standard central venous pressure monitoring. METHODS: This was an observational study of open cardiac surgeries from 2010 to 2018. Patients with pulmonary artery catheter insertion were identified and matched against patients without pulmonary artery catheter insertion via 1:1 nearest neighbor propensity matching. Multivariable analysis was performed to assess the impact of pulmonary artery catheterization on operative mortality in the overall cohort, as well as recent heart failure, mitral valve disease, and tricuspid insufficiency subgroups. RESULTS: Of the 11,820 patients undergoing (Society of Thoracic Surgeons indexed) coronary or valvular surgery, 4605 (39.0%) had pulmonary artery catheter insertion. Propensity score matching yielded 3519 evenly balanced pairs. Compared with central venous pressure monitoring, pulmonary artery catheter use was not associated with improved operative mortality in the overall cohort or in the recent heart failure, mitral valve disease, or tricuspid insufficiency subgroups. Intensive care unit length of stay was longer (P < .001), and there were more packed red blood cell transfusions in the pulmonary artery catheterization group (P < .001); however, postoperative outcomes were otherwise similar, including stroke, sepsis, and new renal failure (P > .05). CONCLUSIONS: These findings suggest that pulmonary artery catheterization may have limited benefit in cardiac surgery.
引用
- Brown JA, Aranda-Michel E, Kilic A, et al. The impact of pulmonary artery catheter use in cardiac surgery. J Thorac Cardiovasc Surg. 2021. PMID: 33642109. doi:10.1016/j.jtcvs.2021.01.086
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。